Latest Issue

    2013 Year 19 Vol. 4 Issue

      OriginalPaper

    • Chun-sheng Li,Hong-bin Deng,Dian-dong Li,Zhao-he Li
      2013, 19(4): 243-252. DOI: 10.1007/s11655-013-1432-8
      Abstract:To provide a better service for senior health care, we summarized screening studies of traditional Chinese anti-aging materia medica (TCAM). We collected and analyzed literature of TCAM screening studies using the lifespan test and animal models of aging from 1984 to 2012. We found 26 screening methods for TCAM, and 153 single herbs or active ingredients of TCAM that have been screened out during the past 28 years. The cell lifespan test, the fruit fly lifespan test, and D-galactose aging model were the most widely used and intensively studied screening methods. However, the method for establishing the D-galactose aging model needs to be standardized, and the D-galactose aging model cannot completely be a substitute for the normal aging mouse model. Great success has been achieved in screening studies in TCAM. To further improve screening studies in TCAM, we suggest that the D-galactose aging model be incorporated into the lifespan test in the New Drugs of Traditional Chinese Medicine Research Guide.  
      Keywords:Chinese anti-aging materia medica;lifespan test;animal model of aging;screening research   
      1364
      |
      1028
      |
      10
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335224 false
      Published:2021-08-27
    • Lai-yi Wong,Ping-chung Leung,Suet-yee Pang,King-fai Cheng,Chun-kwok Wong,Wai-kei Lam,Kwok-pui Fung,Tak-fai Lau,Yee-kit Tse,Chi-yui Kwok
      2013, 19(4): 253-259. DOI: 10.1007/s11655-012-1269-6
      Abstract:To investigate the efficacy of a herbal formula in the prevention of influenza or influenza-like syndrome among elderies residing in old-people’s home in Hong Kong. The secondary objectives are to investigate the quality of life (QOL) and symptomology changes among the herbal users and to evaluate the safety of this formula. In ten old people’s home or community centres in New Territories, Hong Kong, 740 eligible subjects agreed to join the study and were randomized to receive a herbal formula or a placebo on alternate days over 8 weeks. Among those 740 participants, 113 had provided blood samples for immunological assessments before and after the study drug. Assessments were done at 0, 4, 8 and 12 weeks. Participants were instructed to keep a daily record of body temperature and any symptoms as sore throat, myalgia, running nose or cough, and to report to assessor accordingly. Those reporting body temperature of 37.8 °C and above would be visited and a proper nasopharyngeal swab be taken for viral study. Seventy-two participants developed influenza-like-symptoms but none of them was proven influenza in their nasopharyngeal swabs, 40 of these patients belonged to the herbal group and 32 to the placebo group, without significant differences between groups. The difference on the changes in QOL between the two groups was not statistically significant. However, in the immunological study, the natural killer cell absolute count was significantly increased in the herbal group compared with the placebo group (463±253 vs 413±198, P<0.05). The herbal preparation was not effective compared with placebo in the prevention of influenza-like syndrome. It was however safe and possibly supporting immunological responses.  
      Keywords:Complementary Medicine;Influenza;herbal treatment   
      1292
      |
      731
      |
      4
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335187 false
      Published:2021-08-27
    • Yang Xie,Jian-sheng Li,Xue-qing Yu,Su-yun Li,Nian-zhi Zhang,Ze-geng Li,Su-ju Shao,Lian-xiang Guo,Lin Zhu,Yi-jie Zhang
      2013, 19(4): 260-268. DOI: 10.1007/s11655-013-1438-2
      Abstract:To evaluate the efficacy of Bufei Yishen Granule (补肺益肾颗粒, BFYSG) combined with Shufei Tie (舒肺贴) acupoint sticking therapy on quality of life of patients with stable chronic obstructive pulmonary disease (COPD). A multi-center, double-blinded, double-dummy and randomized controlled method was adopted in this trial. A total of 244 patients were randomly assigned to a trial group and a control group according to the random number, each with 122 patients; treatment allocation occurred when the participants met the inclusion criteria and signed the informed consent form. In the trial group, patients were treated with BFYSG combined with “Shufei Tie” acupoint sticking therapy and sustained-release theophylline dummy, and in the control group patients were treated with oral sustained-release theophylline and BFYSG dummy combined with “Shufei Tie” acupoint sticking therapy dummy. The therapeutic course for two groups was 4 months and the follow-up was 6 months. The frequency and duration of acute exacerbation calculated by adding up each frequency and duration of acute exacerbation in treatment and follow-up time respectively, the quality of life measured by the World Health Organization Quality of Life (WHOQOL)-BREF scale and adult COPD quality of life (COPD-QOL) scale were observed. Among the 244 enrolled patients, 234 were screened for full analysis set (FAS); 221 were screened for per-protocol analysis set (PPS). After 4-month treatment and 6-month follow-up there were differences between the trial group and the control group in frequency of acute exacerbation (FAS: P=0.013; PPS: P=0.046); duration of acute exacerbation (FAS: P=0.005; PPS: P=0.006); scores of physiological, psychological and environment aspects of the WHOQOL-BREF questionnaire (FAS: P=0.002, P=0.006, P=0.000; PPS: P=0.00, P=0.001, P=0.000); scores of daily living ability, social activity, depression symptoms aspects of the COPD-QOL questionnaire (FAS: P=0.000, P=0.000, P=0.006; PPS: P=0.002, P=0.001, P=0.001). BFYSG combined with acupoint sticking therapy could improve the quality of life of patients with stable COPD.  
      Keywords:Chinese Medicine;Chronic Obstructive Pulmonary Disease;Bufei Yishen Granule;acupoint sticking therapy;quality of life   
      1528
      |
      946
      |
      6
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335144 false
      Published:2021-08-27
    • Seung-Yeon Cho,Mia Kim,Jong Joo Sun,Geon-Ho Jahng,Hengjun J. Kim,Seong-Uk Park,Woo-Sang Jung,Chang-Nam Ko,Jung-Mi Park
      2013, 19(4): 269-276. DOI: 10.1007/s11655-013-1436-4
      Abstract:To investigate brain activity patterns during acupuncture in stroke patients, and to compare the result with normal subjects using functional magnetic resonance imaging (fMRI). A total of 11 stroke patients with motor weakness and 10 healthy subjects were studied. fMRI was performed during acupuncture on the left side at points Quchi (LI11) and Zusanli (ST36). Data were analyzed using statistical parametric maps of brain activation induced by acupuncture stimulation. The results showed that stimulation of both LI11 and ST36 produced significantly different brain activation patterns between the two groups. The normal group showed a greater overall activation than the stroke group. In the normal group, parts of the frontal lobe, parietal lobe, sub-lobar, cerebellum and midbrain regions were activated by acupuncture at the left LI11. On the other hand, only the right side of the inferior parietal lobule region was activated in the stroke patients. When the left ST36 was stimulated in the normal group, both sides of the frontal lobe, parietal lobe, temporal lobe, and sub-lobar, and the left side of occipital lobe, and the right side of cerebellum and midbrain regions were activated. For the same stimulation in the stroke group, only both sides of the inferior parietal lobule and cerebellum regions were activated (P<0.05, cluster level). Deactivation pattern was not noted during any acupuncture stimulation in both groups. Brain signal activations during the same acupuncture were different between the healthy and the stroke patients, and the effects showed a correlation of different acupuncture points.  
      Keywords:acupuncture;functional magnetic resonance imaging;stroke;LI11;ST36;basal ganglia   
      1428
      |
      702
      |
      19
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335086 false
      Published:2021-08-27
    • Siwoo Lee,Myeong Soo Lee,Deok Hwa Choi,Su Kyung Lee
      2013, 19(4): 277-281. DOI: 10.1007/s11655-013-1425-7
      Abstract:To investigate the treatment time dependence of electroacupuncture (EA) on Neiguan (PC6) for preventing postoperative nausea and vomiting (PONV). One hundred and seventy-eight patients, who had received intravenous patient-controlled analgesia (PCA) with Fentanyl, were assigned randomly to three groups using random numbers: a pre-operative EA group (PrEA), a post-operative EA group (PoEA), and a non-acupuncture control group (NC). An anesthetist evaluated the incidence and severity of nausea and vomiting for 48 h after surgery blindly. The main outcomes were severity and freguency of PONV, which were measured with a self-reported questionnaire and a confirmation from the anesthetist. The data were analyzed with ANOVA and Z-test. The incidence of nausea and vomiting was significantly lower in the PrEA group than the NC group during 48 h after surgery (P<0.01, P<0.05). The incidence of vomiting was also significantly lower in the PrEA group than the PoEA group (P<0.05). The PoEA subjects evidenced no significant differences compared with the NC subjects in terms of the incidence of nausea and vomiting (P<0.05). The severity of nausea was significantly lower in the PrEA group than in the NC and PoEA groups (P<0.05). EA on PC6 is effective in the prevention of PONV, and pre-operative acupuncture is more effective than post-operative acupuncture.  
      Keywords:electroacupuncture;Neiguan (PC6);postoperative nausea and vomiting   
      1378
      |
      906
      |
      25
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335051 false
      Published:2021-08-27
    • Chang-gui Chen,Hui-ying Wang,Yu Dai,Jiao-li Wang,Wei-hua Xu
      2013, 19(4): 282-288. DOI: 10.1007/s11655-013-1410-1
      Abstract:To investigate the effect of Tripterygium polyglycosid on establishing airway eosinophil infiltration and related airway hyperresponsiveness of asthmatic mice. A mature murine asthmatic model was made with ovabulmin sensitized and challenged C57BL/6 mice. Forty mice were divided into four groups with 10 mice in each group: mice sensitized and challenged with saline (WS group), mice sensitized and challenged with ovalbumin (WO group), mice sensitized and challenged with ovalbumin and treated with Tripterygium polyglycosid (TP group) and Dexamethasone (DXM group). The mice were intraperitoneally injected with 20 μg chicken ovabulmin emulsified in injected alum on days 0 and 14, then were challenged with an aerosol generated from 1% ovabulmin on days 24, 25 and 26. Tripterygium polyglycosid was injected intraperitoneally at 50 mg/kg on days 25, 26 and 27 after ovabulmin challenge. Dexamethasone was administrated to mice at 2 mg/kg on day 21, 23 before ovabulmin challenge. The airway hyperresponsiveness, mucus production, eosinophils in parabronchial area and bronchoalveolar lavage fluid and the level of interleukin-5, granulo-macrophage clone stimulating factor in bronchoalveolar lavage fluid were measured as indexes of inflammation. Tripterygium polyglycosid treatment after ovabulmin challenge completely inhibited eosinophil infiltration in bronchoalveolar lavage fluid [(0.63±0.34)×104 vs. (75.0±14.8)×104, P<0.05] and the peribrochial area (12.60±3.48 mm2 vs. 379.0±119.3 mm2, P<0.05), mucus overproduction in airway (2.8±1.7 vs. 7.1±5.6, P<0.05), and increased interleukin-5 levels in bronchoalveolar lavage fluid (28.8±2.8 pg/mL vs. 7.5±3.5 pg/mL, P<0.05). Meanwhile, Tripterygium polyglycosid treatment after ovabulmin challenge also partially inhibited airway hyperresponsiveness. The level of granulo-macrophage clone stimulating factor in bronchoalveolar lavage fluid didn’t change with drugs intervention. The administration of Tripterygium polyglycosid could inhibit the established airway inflammation and reduce the airway hyperresponsiveness of allergic asthmatic mice. It provides a possible alternative therapeutic for asthma.  
      Keywords:Tripterygium polyglycosid;Asthma;mouse;airway hyperresponsiveness;eosinophils   
      1119
      |
      814
      |
      6
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16335001 false
      Published:2021-08-27
    • Xin Deng,Jian Liang,Zhen-wei Liu,Fa-sheng Wu,Xuan Li
      2013, 19(4): 289-296. DOI: 10.1007/s11655-013-1433-7
      Abstract:To investigate the efficacy and safety of the Fuzheng Huayu Tablet (扶正化瘀片, FZHYT), which is used to reinforce qi and resolve stasis in patients with posthepatitic cirrhosis (PHC). A multicenter, randomized, controlled clinical trial was conducted in 180 patients with PHC. The patients were randomly assigned using random numbers to a treatment group treated with FZHYT and a placebo group; the treatment course was 6 months for both groups. Overall response, adverse events (AEs), and the 2-year survival rate were assessed after treatment. Evaluations were made on changes in liver function, liver fibrosis, coagulation, hemodynamics, degrees of esophagogastric varices, ascites, quality of life (QOL), and scores of main symptoms. The overall response was significantly higher in the treatment group than the placebo group (86.7% vs. 62.2%, P<0.01). Patients in both groups had significant improvements in liver function [total bilirubin (TBIL), albumin (ALB)], liver fibrosis [hyaluronic acid (HA), type IV collagen (CIV)], coagulation [prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), and thrombin time (TT)], hemodynamics portal venous flow (PVF), and splenic vein flow (SVF) after treatment. Between-group comparisons showed that compared with the placebo group patients in the treatment group achieved significantly greater improvements in TBIL, ALB, HA, C IV, PT, APTT, PVF, SVF, time to ascites resolution, 2-year survival, QOL, and symptom scores (P<0.05 or P<0.01). There were no significant AEs during the treatment. FZHYT is effective and safe for the treatment of hepatic cirrhosis as it is associated with improved liver function, liver fibrosis, coagulation, portal hypertension state, QOL, 2-year survival rate, and fewer AEs.  
      Keywords:posthepatitic cirrhosis;Fuzheng Huayu Tablet;blood-activating;stasis-resolving;clinical trial   
      1047
      |
      1005
      |
      6
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16334953 false
      Published:2021-08-27
    • Hun-Soo Lee,Hye-Lim Park,Seung-Jin Lee,Byung-Cheul Shin,Jun-Yong Choi,Myeong Soo Lee
      2013, 19(4): 297-306. DOI: 10.1007/s11655-013-1431-9
      Abstract:To evaluate the effectiveness of scalp acupuncture (SA), a modern acupuncture technique specialized to neurological disorders, in managing motor function and symptoms for Parkinson’s disease (PD) patients. Two independent reviewers extracted data from all of the randomized clinical trials (RCTs) that assessed the efficacy of SA for PD compared with conventional therapies (CTs). Sixteen electronic databases were searched. The risk of bias was appraised with the Cochrane Collaboration tool, and the reporting of the included studies was evaluated by the Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist and the revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) guidelines. In total, 4 RCTs met the inclusion criteria. As assessed by the Unified PD Rating Scale (UPDRS), 2 RCTs showed that SA combined with CTs proved superior to CTs alone [60 cases; weighted mean difference, −3.94; 95% confidence interval (CI), −6.05 to −1.84, P=0.01; I2 =0%]. Based on the Webster scale, however, 3 RCTs showed no superior effect of SA when combined with CTs with high heterogeneity (154 cases; risk ratio, 1.29; 95% CI, 0.79 to 2.12, P=0.30; I2 =84%). The Cochrane risk of bias, adherence to the CONSORT and the STRICTA checklist showed that the quality of all the included RCTs was generally low. The result of our systematic review and meta-analysis suggested that the effectiveness of SA for PD is promising, however, the evidence is not convincing. A sham-controlled RCT design that adheres to the CONSORT and STRICTA guidelines to overcome methodological weakness and that includes a large sample size is strongly recommended to confirm the precise effect of SA on PD.  
      Keywords:Scalp Acupuncture;Parkinson’s disease;randomized controlled trials;systematic review;metaanalysis   
      1724
      |
      915
      |
      27
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16334899 false
      Published:2021-08-27
    • Arthur de Sá Ferreira,Agnaldo José Lopes
      2013, 19(4): 307-314. DOI: 10.1007/s11655-013-1412-z
      Abstract:Pulse examination was probably the earliest attempt to distinguish between health and illnesses. Starting at the pre-Hippocratic era, Chinese medicine practitioners developed techniques for pulse examination and defined pulse images based on their perceptions of pulse waveforms at the radial artery. Pulse images were described using basic variables (frequency, rhythm, wideness, length, deepness, and qualities) developed under philosophical trends such as Taoism and Confucianism. Recent advances in biomedical instrumentation applied to cardiology opened possibilities to research on pulse examination based on ancient Chinese medical theories: the pulse wave analysis. Although strongly influenced by philosophy, some characteristics used to describe a pulse image are interpretable as parameters obtained by pulse waveform analysis such as pulse wave velocity and augmentation index. Those clinical parameters reflect concepts unique to Chinese medicine — such as yinyang — while are based on wave reflection and resonance theories of fluids mechanics. Major limitations for integration of Chinese and Western pulse examination are related to quantitative description of pulse images and pattern differentiation based on pulse examination. Recent evidence suggests that wave reflection and resonance phenomena may bridge Chinese medicine and cardiology to provide a more evidence-based medical practice.  
      Keywords:Blood Circulation;palpation;diagnosis;Chinese Medicine;pulse waveform   
      1201
      |
      743
      |
      8
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16334833 false
      Published:2021-08-27

      ReviewPaper

    • Wei Tian,Si-yu Chen
      2013, 19(4): 315-320. DOI: 10.1007/s11655-013-1437-3
      Abstract:Oridonin, a diterpenoid isolated from Rabdosia rubescens, has been proven to possess various pharmacological and physiological effects such as anti-inflammation, anti-bacterial, and anti-neoplastic, although in recent years, more attention has been paid to its anti-neoplastic effects. For example, oridonin can trigger cell cycle arrest, apoptosis, and autophagy in different neoplastic cell lines. This review summarizes the considerable knowledge about the action mechanisms of oridonin that has been studied in recent years. The present observations reveal the novel anti-neoplastic effects of oridonin, suggesting that it may be effective as a potent alternative or adjunct drug to conventional chemotherapy.  
      Keywords:oridonin;anti-neoplasm;cell cycle arrest;apoptosis;autophagy   
      1371
      |
      778
      |
      28
      <HTML>
      <Meta-XML>
      <CITATION> <Bulk Citation> 16334771 false
      Published:2021-08-27
    0